Asthma is one of the main chronic diseases in childhood and it is characterized by the inflammation of airways. Individuals with chronic lung disease are more susceptible to present reduction in exercise tolerance due to pulmonary limitations. The pulmonary rehabilitation may improve the physical capacity in asthmatic patients, as observed in other chronic lung diseases.
The asthmatic patient's clinical changes may impair their functional capacity and exercise tolerance. Thus, the treatment of these individuals should be extended to pulmonary rehabilitation. Randomized clinical trials have shown interesting results, whether in cardiopulmonary conditions, quality of life or in the number of crises, after applying pulmonary rehabilitation program in asthmatic children and adolescents. In a systematic review on physical training with asthmatic children and adolescents the authors concluded that physical activity should be recommended to this population, although some issues have not yet been clarified due to limitations in the clinical trial. The control of the disease has not been evaluated by specific questionnaires in any study. The assessment of inflammatory markers was rarely addressed and the same occurred in the quality of life after physical training. In addition, it is possible to question the intensity and frequency of training, factors that can significantly contribute to the intervention results. All these information let us know that is necessary a randomized control trial to answer questions about physical characteristics, quality of life, inflammatory markers, and muscles strength.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
66
Aerobic training
Chest physiotherapy: Flutter and muscle stretching
Fernanda C Lanza
São Paulo, Brazil
Physical capacity as measure by distance walked of shuttle walk test and oxygen consumption (VO2)
Modified shuttle test was conducted
Time frame: Physiscal capacity will be measured at the beginning and at the end of the protocol (after 8 weeks)
Muscle strength as measure by electromyography (EMG)
1 maximal repetition was performed
Time frame: Muscles strenght will be measured at the begening and at the end of the protocol (after 8 weeks).
Muscle endurance as measure by electromyography (EMG)
Time frame: Muscles endurance will be measured at the begening and at the end of the protocol (after 8 weeks).
Quality of life measured by Pediatric questionnaire
Time frame: Quesitionnaire will be measured at the begening and at the end of the protocol (after 8 weeks).
Inflammatory markers as measure by interleukines
Time frame: Inflamatory markers will be measured at the begening and at the end of the protocol (after 8 weeks).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.